Lenalidomide in cancer cachexia: a randomized trial of an anticancer drug applied for anti‐cachexia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lenalidomide in cancer cachexia: a randomized trial of an anticancer drug applied for anti‐cachexia

Published:2022-01 Issue:1 Volume:5 Page:68-76
ISSN:2617-1619
Container-title:JCSM Rapid Communications
language:en
Short-container-title:JCSM Rapid Communications

Author:

Blum David¹^ORCID,Hertler Caroline¹,Oberholzer Rolf²,Wolf‐Linder Susanne³,Joerger Markus²,Driessen Christoph²,Strasser Florian²

Affiliation:

1. Palliative Care Center University Hospital Zurich Zurich Switzerland

2. Clinic for Medical Oncology and Haematology Cantonal Hospital St. Gallen St. Gallen Switzerland

3. School of Health Professions, Institute of Nursing Zurich University of Applied Sciences (ZHAW) Winterthur Switzerland

Funder

Celgene

Publisher

Wiley

Subject

Industrial and Manufacturing Engineering,Materials Science (miscellaneous),Business and International Management

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rco2.54

Reference25 articles.

1. Update on anorexia and cachexia

2. Management of Cancer Cachexia: ASCO Guideline

3. Cancer cachexia—pathophysiology and management

4. Prognostic effect of weight loss prior tochemotherapy in cancer patients

5. Prognostication in advanced cancer: update and directions for future research

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on the treatment of cancer cachexia;Drug Discovery Today;2023-09

2. Cachexia: A systemic consequence of progressive, unresolved disease;Cell;2023-04

3. Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysis;The Lancet Haematology;2022-12

4. Cancer Cachexia: Signaling and Transcriptional Regulation of Muscle Catabolic Genes;Cancers;2022-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3